Could investing $10,000 in this ASX 200 share make you a millionaire?

Turning $10k into seven figures could seem like magic, but stock investors can do it with thorough research and patience.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Becoming a millionaire after starting with just $10,000 seems unlikely, but it's entirely possible with the combined power of stocks and compounding.

Of course, your portfolio should be well diversified in order to reduce the risk of disaster.

But taking a look at one specific example can demonstrate how reaching $1 million is within the grasp of the ordinary punter.

Let's break it down:

A man wearing a white coat holds his hands up and mouth open with joy.

Image source: Getty Images

Check out this ASX 200 beauty

As a member of the S&P/ASX 200 Index (ASX: XJO), Neuren Pharmaceuticals Ltd (ASX: NEU) is no small cap.

The $2.9 billion biotech outfit develops treatments for rare neurological conditions.

While it has a batch of products under testing and pending approval, it already has the world's only treatment for Rett Syndrome, Daybue, in the commercial market.

Daybue is licensed to the $7 billion US company Acadia Pharmaceuticals Inc (NASDAQ: ACAD).

Neuren Pharmaceuticals receives royalty payments from this agreement, providing it revenue to work on its future pipeline.

With revenue pouring in and favourable clinical trial results coming through, the Neuren share price has performed incredibly in recent times.

Just this month, the stock has rocketed 55%, to add to a 45% rise in November.

If you go back to the start of the year, Neuren shares have almost tripled.

For longer-term investors, the five-year return is a phenomenal 1,593%.

That means that $10,000 of Neuren shares purchased a half-decade ago would now be worth around $160,000.

Where is my million?

Nice work already. But what about the million, you ask?

The chances are even Neuren Pharmaceuticals could not keep up the breakneck pace of 74% compound annual growth rate (CAGR).

Let's assume as the business matures, the CAGR settles down to a more modest 15%.

If you can keep adding $500 each month to the $160,000 parcel, your Neuren shares will have grown to a million bucks after 12 years.

Past performance is never an indicator of the future, but this example shows how $10,000 can turn into seven figures using ASX 200 shares.

Good luck with your investments.

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Investing Strategies

Hand with Australian dollar notes handing the money to another hand symbolising ex-dividend date.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

I think these businesses have attractive payouts!

Read more »

Happy work colleagues give each other a fist pump.
Blue Chip Shares

3 ASX blue chip shares to buy with $10,000

Looking for blue chips? These three could be just what you need.

Read more »

Excited woman holding out $100 notes, symbolising dividends.
Dividend Investing

I'd buy 11,429 shares of this ASX 200 stock to aim for $200 a month of passive income

This could be one of the leaders for dividend income.

Read more »

Three excited business people cheer around a laptop in the office
Growth Shares

How I would invest $10,000 across ASX growth shares in May

The recent sell-off has changed the starting point for a number of growth shares. For long-term investors, that can make…

Read more »

Children skipping and jumping up a hill.
Small Cap Shares

Morgans has a buy recommendation on this ASX small cap 

This small cap is drawing positive attention today.

Read more »

Stacks of coins in a row with each higher than the last, and a person standing on top of each one watching them grow.
Dividend Investing

How I'd invest $2,000 in high-yield ASX 300 shares

I rate these businesses as strong buys for the long-term.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Dividend Investing

3 high-yield ASX dividend shares paying 9% (or more)

These ASX dividend shares pay a consistent dividend payment to shareholders, and at a high rate.

Read more »

Woman holding $50 notes with a delighted face.
Dividend Investing

3 ASX dividend stocks with 4% yields to buy for a winning income portfolio

There are still income stocks out there with hefty yields...

Read more »